Darcy Frear, Ph.D., is Associate Director of Global Regulatory Policy at BridgeBio, where she leads cross-industry collaborations to advance biomarker and patient experience data initiatives. Her work focuses on shaping FDA policy and driving innovative, patient-centered approaches to rare disease drug development. A published author and active BIO committee co-chair, she brings a blend of scientific rigor, policy insight, and collaborative leadership to the evolving regulatory landscape.